This contract expires in 169 days (Feb 28, 2027).

Browse related active opportunities

NO SET ASIDE USED.

CYPROTEX US LLC - EO 14398 - PURCHASE OF DEVELOPMENT OF A HUMAN NEURAL NETWORK FORMATION NEW APPROACH METHOD FOR THE EVALUATION OF POTENTIAL DEVELOPMENTAL NEUROTOXICITY

PIID: 75F40126P00176Solicitation ID: 75F40126Q00291
Signed Date: Aug 10, 2026Effective Date: Sep 1, 2026End Date: Closes in 169 days
Award $
$71K
Vendor
CYPROTEX US LLC
NAICS
541690
Signed Date
Aug 10, 2026

Key Details

Dollars Obligated
$70,500
Base & All Options
$70,500
Awarding Sub-Agency
Food and Drug Administration
Product Service Code
B599 - SPECIAL STUDIES/ANALYSIS- OTHER
Extent Competed
NOT COMPETED
Number of Offers
1
Place of Performance
FRAMINGHAM, MA

Description

EO 14398 - PURCHASE OF DEVELOPMENT OF A HUMAN NEURAL NETWORK FORMATION NEW APPROACH METHOD FOR THE EVALUATION OF POTENTIAL DEVELOPMENTAL NEUROTOXICITY

Context & Analysis

On Aug 10, 2026, Department of Health and Human Services obligated $70,500 to CYPROTEX US LLC for eo 14398 - purchase of development of a human neural network formation new approach method for the evaluation of potential developmental neurotoxicity. The award is classified under NAICS 541690 — OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES. Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in FRAMINGHAM, MA. The contract is scheduled through Feb 28, 2027 — approximately 6 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541690 — related awards are listed below.

Contractor Information

Contractor: CYPROTEX US LLC
UEI: YNGLSAF57T14
Location: FRAMINGHAM, MA
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related